Widely used:Recently Viewed
Clear All
$923 Mln
83.43
3.55
108.72
1.69
5.3 %
--
0 %
8.71
283284
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
PetIQ Inc. Class A (PETQ)
| 56.30 | 1.11 | 36.59 | 46.58 | 6.58 | 2.48 | -- |
|
BSE Sensex*
| 12.29 | -0.08 | 1.40 | 22.91 | 11.08 | 16.58 | 11.81 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|
|
PetIQ Inc. Class A (PETQ)
| 114.21 | -59.40 | -40.94 | 53.49 | 6.73 | 7.42 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
$923.02 Mln
$1,134.33 Mln
$0.00 Mln
$84.13 Mln
$460.59 Mln
High
$15.09 - 30.89
29,668,500
NASDAQ: PETQ
Eagle, ID
https://petiq.com
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm... preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. Read more
The total asset value of PetIQ Inc Class A (PETQ) stood at $ 1,077 Mln as on 30-Jun-24
The share price of PetIQ Inc Class A (PETQ) is $30.87 (NASDAQ) as of 04-Oct-2024 16:00 EDT. PetIQ Inc Class A (PETQ) has given a return of 6.58% in the last 3 years.
PetIQ Inc Class A (PETQ) has a market capitalisation of $ 923 Mln as on 04-Oct-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of PetIQ Inc Class A (PETQ) is 3.55 times as on 04-Oct-2024, a 22% discount to its peers’ median range of 4.58 times.
The P/E ratio of PetIQ Inc Class A (PETQ) is 83.43 times as on 04-Oct-2024, a 23% discount to its peers’ median range of 108.72 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the PetIQ Inc Class A (PETQ) and enter the required number of quantities and click on buy to purchase the shares of PetIQ Inc Class A (PETQ).
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.
The CEO & director of Mr. McCord Christensen. is PetIQ Inc Class A (PETQ), and CFO & Sr. VP is Mr. McCord Christensen.
There is no promoter pledging in PetIQ Inc Class A (PETQ).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,093
|
|
|
841
|
|
|
717
|
|
|
673
|
| PetIQ Inc. Class A (PETQ) | Ratios |
|---|---|
|
Return on equity(%)
|
5.3
|
|
Operating margin(%)
|
6.52
|
|
Net Margin(%)
|
1.16
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of PetIQ Inc Class A (PETQ) was $0 Mln.
$0.03
